Oncolytics Biotech's market cap is currently $57.05M. The company's EPS TTM is $-0.267; its P/E ratio is ―; Oncolytics Biotech is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -403.00K	C$ -392.00K	C$ -452.06K	C$ -446.19K	C$ -485.57K
Operating Income	C$ -33.79M	C$ -28.57M	C$ -26.23M	C$ -25.46M	C$ -20.69M
EBITDA	C$ -33.71M	C$ -26.83M	C$ -25.80M	C$ -25.37M	C$ -20.02M
Net Income	C$ -27.75M	C$ -24.84M	C$ -26.30M	C$ -19.55M	C$ -45.55M
Balance Sheet
Cash & Short-Term Investments	C$ 34.91M	C$ 32.14M	C$ 41.26M	C$ 31.22M	C$ 14.15M
Total Assets	C$ 38.82M	C$ 37.33M	C$ 45.88M	C$ 34.35M	C$ 19.66M
Total Debt	C$ 423.00K	C$ 373.00K	C$ 654.75K	C$ 402.06K	C$ 506.27K
Net Debt	C$ -34.49M	C$ -11.29M	C$ -40.61M	C$ -30.82M	C$ -13.64M
Total Liabilities	C$ 11.26M	C$ 10.83M	C$ 9.78M	C$ 9.59M	C$ 19.77M
Stockholders' Equity	C$ 27.56M	C$ 26.50M	C$ 36.10M	C$ 24.75M	C$ -107.89K
Cash Flow
Free Cash Flow	C$ -28.46M	C$ -23.41M	C$ -22.72M	C$ -22.10M	C$ -19.92M
Operating Cash Flow	C$ -28.45M	C$ -23.36M	C$ -22.43M	C$ -22.07M	C$ -19.91M
Investing Cash Flow	C$ 20.22M	C$ -20.40M	C$ -285.95K	C$ -29.30K	C$ -10.90K
Financing Cash Flow	C$ 31.99M	C$ 12.21M	C$ 33.02M	C$ 39.77M	C$ 21.02M

Currency in CAD

Oncolytics Biotech Earnings and Revenue History

Income Statement >

Oncolytics Biotech Debt to Assets

Balance Sheet >

Oncolytics Biotech Cash Flow

Cash Flow >

Oncolytics Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing